News
908 Devices Reports Second Quarter 2021 Financial Results and Raises 2021 Revenue Outlook
908 Devices Expands Scientific Advisory Board, Creates Dedicated Proteomics Panel
908 Devices Expands Strategic Distribution Network in APAC, Europe, and the Americas
908 Devices and Transcenta’s Joint Innovation Partnership Accelerates Biopharma Development
908 Devices to Report Second Quarter Financial Results on August 4, 2021
908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights
908 Devices Appoints Marcia Eisenberg, Ph.D., Chief Scientific Officer, Labcorp Diagnostics, to its Board of Directors
908 Devices to Participate in the William Blair 41st Annual Growth Stock Conference
908 Devices Reports First Quarter 2021 Financial Results and Reiterates 2021 Revenue Outlook
908 Devices Launches New Aerosol Module for Handheld MX908
908 Devices Increases Focus on Biotherapeutics with Expansion of Scientific Advisory Board
908 Devices and Bio-Techne Announce Joint Collaboration
email Subscribe to Our Newsletter Signup to receive new product updates, technical tips and more.